ID   PP4P2_RAT               Reviewed;         257 AA.
AC   Q4V888;
DT   16-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2005, sequence version 1.
DT   29-MAY-2024, entry version 112.
DE   RecName: Full=Type 2 phosphatidylinositol 4,5-bisphosphate 4-phosphatase;
DE            Short=Type 2 PtdIns-4,5-P2 4-Ptase;
DE            EC=3.1.3.78 {ECO:0000250|UniProtKB:Q8N4L2};
DE   AltName: Full=PtdIns-4,5-P2 4-Ptase II;
DE   AltName: Full=Transmembrane protein 55A;
GN   Name=Pip4p2; Synonyms=Tmem55a;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-22, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Catalyzes the hydrolysis of phosphatidylinositol-4,5-
CC       bisphosphate (PtdIns-4,5-P2) to phosphatidylinositol-4-phosphate
CC       (PtdIns-4-P) (By similarity). Does not hydrolyze phosphatidylinositol
CC       3,4,5-trisphosphate, phosphatidylinositol 3,4-bisphosphate, inositol
CC       3,5-bisphosphate, inositol 3,4-bisphosphate, phosphatidylinositol 5-
CC       monophosphate, phosphatidylinositol 4-monophosphate and
CC       phosphatidylinositol 3-monophosphate (By similarity). Negatively
CC       regulates the phagocytosis of large particles by reducing phagosomal
CC       phosphatidylinositol 4,5-bisphosphate accumulation during cup formation
CC       (By similarity). {ECO:0000250|UniProtKB:Q8N4L2,
CC       ECO:0000250|UniProtKB:Q9CZX7}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-
CC         bisphosphate) + H2O = a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
CC         inositol-5-phosphate) + phosphate; Xref=Rhea:RHEA:25674,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:57795,
CC         ChEBI:CHEBI:58456; EC=3.1.3.78;
CC         Evidence={ECO:0000250|UniProtKB:Q8N4L2};
CC   -!- SUBCELLULAR LOCATION: Late endosome membrane
CC       {ECO:0000250|UniProtKB:Q8N4L2}; Multi-pass membrane protein
CC       {ECO:0000255}. Lysosome membrane {ECO:0000250|UniProtKB:Q8N4L2}; Multi-
CC       pass membrane protein {ECO:0000255}. Cytoplasmic vesicle, phagosome
CC       membrane {ECO:0000250|UniProtKB:Q9CZX7}; Multi-pass membrane protein
CC       {ECO:0000255}. Cell membrane {ECO:0000250|UniProtKB:Q9CZX7}; Multi-pass
CC       membrane protein {ECO:0000255}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC097492; AAH97492.1; -; mRNA.
DR   RefSeq; NP_001020071.1; NM_001024900.1.
DR   AlphaFoldDB; Q4V888; -.
DR   SMR; Q4V888; -.
DR   STRING; 10116.ENSRNOP00000009375; -.
DR   iPTMnet; Q4V888; -.
DR   PhosphoSitePlus; Q4V888; -.
DR   SwissPalm; Q4V888; -.
DR   jPOST; Q4V888; -.
DR   PaxDb; 10116-ENSRNOP00000009375; -.
DR   Ensembl; ENSRNOT00000009375.8; ENSRNOP00000009375.4; ENSRNOG00000006697.8.
DR   Ensembl; ENSRNOT00055000571; ENSRNOP00055000434; ENSRNOG00055000327.
DR   Ensembl; ENSRNOT00060029878; ENSRNOP00060024088; ENSRNOG00060017480.
DR   Ensembl; ENSRNOT00065026143; ENSRNOP00065020560; ENSRNOG00065015743.
DR   GeneID; 362490; -.
DR   KEGG; rno:362490; -.
DR   UCSC; RGD:1306225; rat.
DR   AGR; RGD:1306225; -.
DR   CTD; 55529; -.
DR   RGD; 1306225; Pip4p2.
DR   eggNOG; KOG4684; Eukaryota.
DR   GeneTree; ENSGT00390000003680; -.
DR   HOGENOM; CLU_087485_0_0_1; -.
DR   InParanoid; Q4V888; -.
DR   OMA; CAHCHDT; -.
DR   OrthoDB; 4112803at2759; -.
DR   PhylomeDB; Q4V888; -.
DR   TreeFam; TF316367; -.
DR   PRO; PR:Q4V888; -.
DR   Proteomes; UP000002494; Chromosome 5.
DR   Bgee; ENSRNOG00000006697; Expressed in quadriceps femoris and 19 other cell types or tissues.
DR   GO; GO:0031902; C:late endosome membrane; ISS:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; ISO:RGD.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0034597; F:phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity; ISO:RGD.
DR   GO; GO:0050765; P:negative regulation of phagocytosis; ISS:UniProtKB.
DR   GO; GO:0046856; P:phosphatidylinositol dephosphorylation; ISS:UniProtKB.
DR   InterPro; IPR019178; PtdIns-P2-Ptase.
DR   PANTHER; PTHR21014:SF5; TYPE 2 PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 4-PHOSPHATASE; 1.
DR   PANTHER; PTHR21014; UNCHARACTERIZED; 1.
DR   Pfam; PF09788; Tmemb_55A; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Cytoplasmic vesicle; Endosome; Hydrolase; Lipid metabolism;
KW   Lysosome; Membrane; Phosphoprotein; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..257
FT                   /note="Type 2 phosphatidylinositol 4,5-bisphosphate 4-
FT                   phosphatase"
FT                   /id="PRO_0000235230"
FT   TRANSMEM        192..212
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        227..247
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   REGION          1..43
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           107..113
FT                   /note="CX5R motif"
FT   COMPBIAS        13..29
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        107
FT                   /evidence="ECO:0000250"
FT   MOD_RES         22
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         33
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9CZX7"
SQ   SEQUENCE   257 AA;  28024 MW;  783E51EA20B1F71F CRC64;
     MAADGVDERS PLLSASHSGN VTPTAPPYLQ ESSPRAELPP PYTAIASPGT SGIPVINCRV
     CQSLINLDGK LHQHVVKCTV CNEATPIKTP PTGKKYVRCP CNCLLICKDT SRRIGCPRPN
     CRRIINLGPI MLISEEQPAQ PALPVQPEGT RVVCGHCGNT FLWMELRFNT LAKCPHCKKI
     SSVGSALPRR RCCAYVTIGM ICIFIGVGLT VGTQDFSRRF HATYVSWAIA YLLGLICLIR
     ACYWGAIRVS YPEHGFA
//
